Serum lipoprotein (a) concentration in patients with nephrotic syndrome and its clinical implication

Abstract

Serum lipoprotein (a) [Lp(a)] concentration was determined in 42 patients with primary nephrotic syndrome (NS) and the relationships between Lp (a) and plasma lipids, apolipoproteins, serum creatinine (Scr), albumin, urinary proteins (Upro) were also analyzed. The results showed that: (1) serum Lp(a) concentrations in the patients with NS were higher than those in healthy controls; (2) the levels of serum Lp(a) were correlated positively with total cholesterol (TO, low density lipoprotein cholesterol (LDL-C), very low density lipoprotein cholesterol (VLDL-C), apolipoprotein B (Apo-B), Upros (Upro). It is concluded that the NS patients had the potential risk of suffering from coronary artery disease, glomerular sclerosis and thrombosis. The remission of NS may partially decrease the serum Lp(a) levels. Further studies are needed to explore the prevention and treatment of dislipedemia in patients with NS.

Keywords

lipoprotein (a) / nephrotic syndrome / dislipedemia

References

[1] OrdonezJ D, RobertH, EllenK, et al. . The risk of coronary artery disease among patients with the nephrotic syndrome. Kidney Int, 1990, 37243-243

[2] MuraiA, MiyaharaT, FujimotoM, et al. . Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Athrosclerosis, 1986, 59199-199

[3] AppelG B, BlumC B, ChienS, et al. . The hyperlipidemia of the nephrotic syndrome, relation to plasma albumin concentration, oncotic pressure, and viscosity. N Eng J Med, 1985, 3121544-1544

[4] SteinbergD, ParthasarphyS, CarewT E, et al. . Beyond cholesterol modification of low density lipoprotein that increase its atherogenity. N Engl JMed, 1989, 320915-915

[5] BrownM S, GoldsteinJ L. Teaching old dogmas new tricks. Nature, 1987, 330113-113

[6] GalleJ, HeinlothA, SchwedlerS, et al. . Effect of HDL and atherogenity lipoprotein on formation of O₂⁻ and rennin release in juxtaglomerular cells. Kidney Int, 1997, 51253-253

[7] DahlenG H, GuytonJ R, ArrarM, et al. . Association of level of lipoprotein (a), plasma lipids and other lipoproteins with coronary artery disease documented by angiography. Circulation, 1986, 74758-758

[8] UtermannG. The mysteries of lipoprotein (a). Science, 1989, 246904-904

[9] KnightB L, PerombelonY F, SoutarA K, et al. . Catabolism of Lp (a) in familial hypercholesterolaemic subjects. Atherosclerosis, 1991, 87227-227

[10] WannerC, RaderD, BartenW, et al. . Elevated plasma Lp(a) in patients with the nephrotic syndrome. Ann Inter Med, 1993, 119263-263

[11] WebbA T, PlantM, ReareleyD A, et al. . Lipid and Lp(a) concentrations in renal transplant patients. Nephrol Dial Transplant, 1992, 7636-636